BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAMED - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAMED
X-ORIGINAL-URL:https://samed.org.za
X-WR-CALDESC:Events for SAMED
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20250917T100000
DTEND;TZID=Africa/Johannesburg:20250917T113000
DTSTAMP:20260516T122116
CREATED:20250721T110913Z
LAST-MODIFIED:20250826T114409Z
UID:15529-1758103200-1758108600@samed.org.za
SUMMARY:Project 18C (SAMED & MCA Collaboration): Medtech & Pharmaceutical Compliance Officers' Forum
DESCRIPTION:We are pleased to invite you to the Medtech and Pharmaceutical Compliance Officers’ Forum on Wednesday\, 17 September 2025\, where we will explore the latest trends\, challenges\, and best practices in compliance risk management within the pharmaceutical and medical technology sectors. The event will feature two crucial topics designed to equip compliance officers with the knowledge and tools necessary to navigate evolving risks. \nAI in Compliance Risk Management  (Ash Aggarwal & Carlotta Cosulich\, IQVIA) \nArtificial Intelligence (AI) is rapidly transforming the compliance landscape\, offering new ways to enhance compliance monitoring\, streamline data analysis\, and reduce human error. However\, the integration of AI also brings with it a set of challenges\, from ethical concerns to regulatory compliance issues. This session will delve into how AI can be leveraged in compliance frameworks\, particularly for the pharmaceutical and medtech industries. Our expert speaker will discuss how AI can help improve compliance monitoring\, while addressing the potential risks\, such as algorithmic bias\, transparency\, and accountability. \nSocial Media Pitfalls and Risk Areas (Elsabé Klinck\, Klinck & Samuels) \nSocial media is an undeniable part of today’s marketing and communication strategies\, but it also presents significant compliance risks. This session will address how pharmaceutical and medtech compliance officers can mitigate the risks associated with social media engagement\, from influencer marketing to sharing medical information. Our expert speaker will provide actionable insights on maintaining compliance\, while ensuring that promotional content and public relations efforts on social media platforms align with legislative and regulatory standards. Key areas of focus will include the prevention of unapproved product promotions and the ethical use of social media in the healthcare space. \nWhy Attend? \n\nGain insights from leading experts on how to integrate AI responsibly within your compliance framework.\nLearn strategies for managing social media risks while maintaining compliance with industry guidelines.\nStay ahead of the curve on emerging compliance challenges in the pharmaceutical and medtech sectors.\n\nAttendance \n\nFree of charge and limited to MCA Members\, SAMED Members and Code Signatories\n\nRegistration \n\nClick Here
URL:https://samed.org.za/event/project-18c-samed-mca-collaboration-compliance-officers-forum/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR